Literature DB >> 18661770

Expression of matrix metalloproteinase 1 and 2 in congenital choledochal cyst and its clinical significance.

Yong-Zhong Mao1, Shao-Tao Tang, Qing-Lan Ruan.   

Abstract

BACKGROUND: The pathogenesis of congenital choledochal cyst (CCC) is still not well elucidated. This study was conducted to detect the expression of matrix metalloproteinase-1 and 2 (MMP-1 and MMP-2) in CCC. The roles of MMP-1 and MMP-2 in CCC formation were also discussed.
METHODS: Specimens of CCC and gallbladders were taken from 53 patients with CCC, including 21 boys and 32 girls aged from 4 months to 17 years (mean: 6.5 years old). Twenty-eight normal gallbladders served as controls. Immunohistochemical method was used to detect the expressions of MMP-1 and MMP-2. Image analysis was made to quantitatively analyze the protein expression.
RESULTS: The expressions of MMP-1 and MMP-2 were located in epithelial cells, matrix cells, and inflammatory cells of the CCC wall. Various expressions were also found in the mucosa membrane cells of the CCC gallbladder. The expressions of MMP-1 and MMP-2 were low in the control group. Quantitatively, the expressions of MMP-1 and MMP-2 in the CCC wall were markedly higher than in the CCC gallbladder and the control group (P<0.01). There was no significant difference between the CCC gallbladder and the control group (P>0.05).
CONCLUSIONS: The expression of MMP-1 and MMP -2 in the CCC wall is higher than in the CCC gallbladder and controls. The over-expression of MMP-1 and MMP-2 may be involved in the pathogenesis of CCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661770     DOI: 10.1007/s12519-008-0026-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  19 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

3.  Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.

Authors:  Jonathan L Eliason; Kevin K Hannawa; Gorav Ailawadi; Indranil Sinha; John W Ford; Michael P Deogracias; Karen J Roelofs; Derek T Woodrum; Terri L Ennis; Peter K Henke; James C Stanley; Robert W Thompson; Gilbert R Upchurch
Journal:  Circulation       Date:  2005-07-12       Impact factor: 29.690

4.  Origin of the long common channel based on pancreatographic findings in pancreaticobiliary maljunction.

Authors:  T Kamisawa; N Egawa; H Nakajima; K Tsuruta; A Okamoto; M Matsukawa
Journal:  Dig Liver Dis       Date:  2005-05       Impact factor: 4.088

5.  Pancreatic disorders associated with anomalous pancreaticobiliary junction.

Authors:  M Sugiyama; Y Atomi; A Kuroda
Journal:  Surgery       Date:  1999-09       Impact factor: 3.982

Review 6.  Regulation of matrix metalloproteinase gene expression.

Authors:  Chunhong Yan; Douglas D Boyd
Journal:  J Cell Physiol       Date:  2007-04       Impact factor: 6.384

Review 7.  Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.

Authors:  Nikolaos P Kadoglou; Christos D Liapis
Journal:  Curr Med Res Opin       Date:  2004-04       Impact factor: 2.580

8.  Congenital choledochal dilatation with emphasis on pathophysiology of the biliary tract.

Authors:  N Iwai; J Yanagihara; K Tokiwa; T Shimotake; K Nakamura
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

9.  Anomalous pancreaticobiliary junction without congenital choledochal cyst.

Authors:  M Sugiyama; Y Atomi
Journal:  Br J Surg       Date:  1998-07       Impact factor: 6.939

10.  Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells.

Authors:  Kenichi Harada; Shusaku Ohira; Kumiko Isse; Satoru Ozaki; Yoh Zen; Yasunori Sato; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.